News
ASX health stocks jumped 1.6% over five days, with wound management house Tetratherix making its ASX debut, breaking the IPO ...
Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...
As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets.
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Stocks rose Monday, with oil prices declining, following a restrained response by Iran to U.S. attacks over the weekend.
Novo Nordisk (NVO) and Hims and Hers Health (HIMS) shares are sinking on an ended partnership, with the former also ...
Crude oil prices rose more than 4% Tuesday on worries about potential damage to the flow of oil because of fighting between Israel and Iran.
U.S. stocks are holding nearly in place as Wall Street waits to hear where the Federal Reserve may be taking interest rates. The S&P 500 was little changed early Wednesday.
The Dow Jones Industrial Average ended Wednesday modestly lower following the Federal Reserve's latest policy update, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results